Citation 102110

FUJIWARA,MT: IJICHI,KS: TOKUHISA,KJ: KATSUURA,KM: SHIGETA,SR: KONNO,KJ: WANG,GYS: UEMURA,DS: YOKOTA,TY: BABA,MN:. (1996). MECHANISM OF SELECTIVE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS BY INGENOL TRIACETATE.. 40(1)

Citation Details

Title	MECHANISM OF SELECTIVE INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS BY INGENOL TRIACETATE.
Authors	FUJIWARA,MT: IJICHI,KS: TOKUHISA,KJ: KATSUURA,KM: SHIGETA,SR: KONNO,KJ: WANG,GYS: UEMURA,DS: YOKOTA,TY: BABA,MN:
Year	1996
Volume	40
Issue	1

Summary

Year: 1996

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
6	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
7	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
9	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	INGENOL-3-5-20-TRIACETATE	ACTIVE
10	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INGENOL-3-5-20-TRIACETATE	INACTIVE
11	SYNCYTIA INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INGENOL-3-5-20-TRIACETATE	ACTIVE
12	GP120 BINDING TO CD4+ CELLS INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	INGENOL-3-5-20-TRIACETATE	INACTIVE
13	RECEPTOR REGULATING EFFECT(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VITRO	INGENOL-3-5-20-TRIACETATE	ACTIVE
14	RECEPTOR REGULATING EFFECT(UNSPECIFIED)	PHARMACOLOGY OF COMPOUND - IN VITRO	INGENOL-3-5-20-TRIACETATE	INACTIVE

Show SPARQL Queries (1)